Oncology Books

Book SynopsisPrimary bile duct cancers are rare and generally aggressive entities. Historically, this disease was managed exclusively with surgical therapy with few long-term survivors. However, with improvements in chemotherapeutics, targeted therapy, interventional radiology techniques and development of alternative surgical approaches, treatment has moved to the utilization of a multidisciplinary care team employing multimodality treatments which has finally led to improvement in outcomes. In this book, Chapter One examines symptoms and the current state of medical and surgical management of bile duct cancer, while Chapter Two discusses the clinical aspects of care of extrahepatic biliary cancers with an emphasis on diagnosis and management. Chapter Three assesses the risk of bile duct cancer among beneficiaries of The Health Insurance Society of Printing Industry (HISPI) using diagnosis-procedure-combination (DPC) data in comparison with general population. Chapter Four concludes with a summary of results for chemotherapy and targeted therapies.

Read more less

Book SynopsisThe blood cell system has provided a model system that has been used by many researchers to investigate how a stem cell can give rise to a wide variety of mature cell types. The principles that emerged in developmental biology have been applied to the structure of tissues throughout the body. However, many of the principles have been challenged by recent findings, changing the way we view blood cell development. In turn, this has impacted our understanding of the origin and nature of leukaemia, as well as cancer in general. Like the development of any body tissue, cancer is an organised and hierarchical tissue with its own identity. A new viewpoint is that the mutations that give rise to cancer re-programme cancer cells to their own abnormal pattern of tissue development. Understanding how the hierarchy of tumour identity differs from that of normal tissue provides important new avenues to the development of new treatments for cancer. No doubt further refinement to our understanding of normal and cancer cells will continue for many years to come. Even so, we appear to be moving towards an exciting prospect of providing the key to unlocking the long standing mystery of primary cellular events that undermine and distort our normal cells and give rise to the disease of cancer. The importance of this is the prospect of developing new treatments for cancer. In particular, the distorted behaviour of cancer cells might be reversible so that they can be restored to their normal state. Diversity, Versatility and Leukaemia examines how normal and cancer cells are inextricably linked, and focuses on the changes to how we view the development of normal cells and the subversion of this process in cancer.

Read more less

Book SynopsisThis book represents the efforts of young oncologists, haematologists, pharmacists and oncology nurses who are highly motivated and encouraged by the significant development of new effective anticancer drugs. Since the discovery of antimetabolites and alkylating agents in the 1940s and 1950s, many new products have been introduced into our daily arsenal not only through chemotherapy agents, but also by means of biological or immunotherapeutic drugs whose side effects differ significantly. The idea of this book was born from a simple observation and confirmation of fact. New doctors in training experience high levels of stress and lack of confidence when confronting cancer patients and explaining a treatment or managing frequent side effects. Patients questions will only add more nervousness, and this will lead to a failure in the doctor-patient relationship, causing the patients mistrust and doctors frustration. Nurses dealing with these patients will suffer pressure too, as many questions regarding antineoplastic drugs will be asked of them and patients expect them to ease their doubts. This feeling of vulnerability in front of a patient, though a part of the maturation process when becoming a professional caretaker, causes discomfort and incertitude. In this context, it is crucial to gain great knowledge about pharmacokinetic and pharmacological features of each active anticancer drug used, as well as the indications, dosages, interactions and toxicities, to be able to face the daily practice of oncology without concerns and manage daily therapeutic complications easily. This may be considered very difficult, taking into account the huge number of active agents doctors manage routinely, but doctors have accepted the challenge and designed a straightforward, comprehensible book to solve this issue. The Easy Book of Cancer Pharmacology provides the means to overcome the problem. It is conceived as an accessible, concise and yet exhaustive tool which displays a vast amounts of knowledge in a very schematic way. It is easy to consult and offers a very practical expertise to develop the ability of managing effectively each antineoplastic agent quickly. It gives the necessary insights to explain this to the patients with confidence. Each chapter reviews one active drug and shows the information with a pragmatic style, and they are divided into different sections. Each section covers distinct aspects of the agent, from general characteristics to more specific details related to clinical pharmacology. In quickly advancing fields such as oncology, such a book is necessary to help update the ever-developing and expanding knowledge of clinicians and patients in an efficient and effective manner.

Read more less

Book SynopsisBreast tumours are one of the most worrisome and challenging problems for surgeons and pathologists. In this book, the authors present research in the study of the epidemiology, management and prevention of breast tumors; some examples of these types of breast cancer are DCIS, LCIS, IDC, ILC, medullary carcinoma, metaplastic carcinoma, papillary carcinoma, adenoid cystic carcinoma, and rare tumors of the breast. This book is useful to surgeons and pathologists, postgraduates in understanding the pathology for the diagnosis, treatment and prevention of these tumors.

Read more less

Book SynopsisCancer risk prediction models provide an important approach to assess risk and susceptibility by identifying individuals at high risk, facilitating the design and planning of clinical chemoprevention trials, and allowing the evaluation of interventions. Conventional breast cancer risk model includes the cumulative estrogen exposure data such as age, age at menarche and menopause, age at first live birth, and use of HRT in risk calculation, since estrogens are the main risk factor for mammary carcinogenesis. The most widely known and commonly used model for breast cancer risk assessment is the Gail model, which focuses primarily on non-genetic risk factors, with limited information on family history. The first chapter of this book examines breast cancer risk assessment models. The following chapters discuss the association between obesity and breast cancer development; current and future standards for treatment of breast cancer and long term care of patients; and mastectomies and voluntarism.

Read more less

Book SynopsisThis book presents original results on the leading edge of cancer research. Chapter One summarizes what is currently known regarding the epigenetic regulation of osteosarcoma pathways and oncogenes, as well as clinical trials of drugs that exert epigenetic regulation. Chapter Two critically discusses the role of ECM-dependent signaling in osteosarcoma progression. Chapter Three illustrates the harmful effects of ultraviolet radiation exposure by focusing on photocarcinogenesis. Chapter Four examines the psychology of sunscreen use and outlines the key psychological factors associated with sunscreen use. Chapter Five reviews the cellular and molecular mechanism of Regulatory T cells (Tregs) and Transforming Growth Factor-β mediating cervical cancer development. Chapter Six examines the affect of the American cranberry extract on expression of insulin-like growth factor-I and insulin-like growth factor binding proteins in human prostate cancer cells in vitro. Chapter Seven discusses the design of synthetic peptides to specifically interfere the papillomavirus binding factor/14-3-3beta binding to restore papillomavirus binding factor apoptotic functions. Chapter Eight examines brain development using correlations between Diffusion Kurtosis and neurite orientation dispersion and density imaging (NODDI) in neonates and young children. Chapter Nine highlights the opportunities that are available to prevent the late effects related to stress and fears, emphasizing the importance of teaching patients resiliency and how to cope.

Read more less

Book SynopsisThe human life is considered most vital of all the living creatures on Earth because humans are bestowed with the highest level of cognition. One can enjoy life if the natural gift, the body, is in a good or healthy condition. A disease is an abnormal condition of the body resulting from infections, toxicity, unfavourable environmental conditions, or illness due to inherited genetic defects in the body. In the past,contagious diseases like the plague resulted in widespread death. About 100 years ago tuberculosis (TB), which is caused by a single bacteria, was one of the deadliest diseases. However, today even a fourth stage TB patient can live a normal life after receiving the allopathic treatment. Unfortunately, that is not the case with cancer. Today cancer is the most dreaded disease and the #1 killer worldwide. Unlike TB, cancer is difficult to treat as there are more than 100 different types of cancers. However, with a communal undying zeal and drive for finding a cure for cancer, a lot of progress has been made recently in treating different types of cancers, some of them resulting in total cure. Understanding Cancer at a Subcellular Level delves into the root cause of cancer, which is the mutations in DNA molecules or genes. Further, it elaborates on the risk factors which cause mutations in genes. The internal causes are either inherited faulty genes from one of the parents or changes in genes due to the cells internal microenvironments; the external risk factors are many, such as age, alcohol, food, tobacco, etc. If your health is in good condition, that means your genes are quite healthy. If DNA or genes are mutated, it leads to cancer development. Multiple mutations in a single gene and multiple mutated genes are needed to develop cancer. Today, with advancements in science and technology, it is possible to offer various treatment options to cancer patients. The book gives details about: i) signs and symptoms of cancer; ii) causes or risk factors of developing mutations in a healthy gene using the concept of molecular biology at the genetic level; iii) different types of genes and cancers; iv) country specific treatment options; v) dealing with cancer; and vi) estimated treatment costs. The last chapter is dedicated to definitions of different terms used in this book. This book covers extremely vital information useful for scientists in research laboratories (such as chemistry, biochemistry, molecular biology, oncology, human genome, bioengineering/genetic-engineering etc.), general physicians, oncologists, all other medical practitioners, students and professors, cancer patients and their relatives and for anyone interested in learning about this abnormality.

Read more less

Book SynopsisBurkitt lymphoma (BL) is a form of non-Hodgkin's lymphoma in which cancer starts in immune cells called B-cells. If left untreated, it is rapidly fatal. Chapter One of this monograph evaluates the aetiology, pathological issues, diagnosis, clinical manifestations, epidemiology, research, innovation and treatment issues of BL using the clinical systematic review research method and experts' opinion analysis approach. Chapter Two reviews the spectrum, unique characteristics and special management considerations when BL develops in specific subgroups of patients with primary immune deficiency disorders. Chapter Three reviews the incidence, clinicopathological and epidemiologic features, treatment and outcome data available in paediatric and adult patients with post solid organ transplant BL. Chapter Four focuses on the pathobiology and the treatment of first-line and relapsed/refractory cases of BL and describes new therapeutic strategies which could improve results in this pathology. Chapter Five examines the therapeutic advances in BL and its variants. Finally, Chapter Six explores and emphasizes the trends and issues in research and innovation in the characteristics, clinical updates and management approaches of BL.Table of ContentsPreface; Burkitt Lymphoma: Diagnosis and Treatment Issues; Burkitt Lymphoma in Patients with Primary Immunodeficiency Disorders; Post Solid Organ Transplant Burkitt Lymphoma; Burkitt Lymphoma; Examining the Therapeutic Advances for Burkitt Lymphoma; Burkitt Lymphoma: Evaluation of Characteristics, Clinical Updates and Management Approaches Trends; Index.

Read more less

Book SynopsisMesothelioma is a type of cancer in which tumors form in the tissue that lines the lungs, heart, stomach, and other organs. While mesothelioma is relatively rare, it represents a serious health crisis as the disease is aggressive and often fatal. This book includes five chapters that detail the treatment and prognosis of the disease as well as the factors that put a person at risk for developing mesothelioma. Chapter One describes the most promising emerging immunotherapy combinations for the treatment of malignant pleural mesothelioma, discussing the biological rational underlying their development as well as the issues surrounding their clinical development. Chapter Two provides an overview of malignant mesothelioma, describing the history of its diagnosis and treatment as well as the role that asbestos exposure and other factors play in its development. Chapter Three revises the role of the main inflammatory and immunological markers as prognostic indicators in malignant pleural mesothelioma and discusses the surgical effects on immune response against cancer. Chapter Four explores the main cancer markers utilized for mesothelioma diagnosis as well as the new developments in the field. Lastly, Chapter Five examines the various surgical options available for removing pleural tumors.Table of ContentsPreface; Mesothelioma: The Advent of Immunotherapy; Malignant Mesothelioma; Inflammatory and Immunological Aspects in the Surgical Management of Malignant Pleural Mesothelioma; New Developments in Mesothelioma Markers; Surgical Approaches to Pleural Tumours; Index.

Read more less

Book SynopsisThis monograph deals with the susceptibility issues in the development of an effective response to antigenicity as presented by emerging or established neoplastic lesions. An attempt has been made to present critical views of the dysfunction of carcinogenesis in terms of evolving immune responses in terms of recruitment of dendritic cell biology. It is within such conceptual framework that autoimmunity presents an attractive response to neoplasia in terms that allow for access to the malignant transformation process. It is significant to potentiate the immune responses that involve the integral immune dimensions that characterise and recharacterise the dynamics of turnover of dendritic cells as the most powerful agents in presentation of neoantigenicity as provided by tumour cell proliferation and spread within the body. The performance of staged dimensions in antigen exposure by tumour cells is critical to the presentation of tumour cells as brought forward by the proposed dynamics of an interface between tumour cells and the tumour microenvironment in the realisation of an extensive autoimmune response with the realisation of performance exposure of the antigenicity as a biologic agent in its own right. This book is aimed to cancer researchers, pathologists, and immunologists with a strong interest in carcinogenesis and cancer cell progression as dictated by proposed immune response to tumour antigenicity.

Read more less

Book SynopsisThis volume includes seven chapters that present some of the latest advancements in cancer research. Chapter One studies the correlation between smoking and cancer using the sequenced human genome. Chapter Two discusses glucose-regulated protein 78-mediated regulation of epithelial-mesenchymal transition, the apoptotic and autophagic signaling pathways, and how it can be used as a therapeutic against cancer. Chapter Three discusses new approaches in the treatment of hodgkin lymphoma. Chapter Four includes a review of the etiology, diagnosis and therapeutic management of rare pancreatic tumors. Chapter Five introduces recent progress on the mechanism of action and predictive biomarkers of mitomycin C using a genome-scale CRISPR/Cas9 knockout screening approach. Chapter Six discusses ultrasonography, endometrial sampling, magnetic resonance imaging, and computed tomography in the context of endometrial cancers. Finally, Chapter Seven discusses treatment options for papillary thyroid carcinoma.

Read more less

Book SynopsisThe purpose of this book is to provide a broad background of several aspects of basic sciences, clinical, therapeutic aspects, and management of endometrial cancer. It provides state-of-the-art information on the molecular genetics, biology, and clinical aspects of premalignant lesions of the endometrium and endometrial cancer. Also, the book chapters provide better understanding of the molecular and cellular events that underlie endometrial cancer. The descriptive and analytical epidemiology of endometrial cancer are presented in Chapter 1. The pathology and molecular diagnosis of endometrial cancer are discussed in Chapter 2. The molecular pathology of endometrial cancer is detailed in Chapter 3. The hereditary aspect of endometrial cancer is highlighted in Chapter 4. Precancerous lesions of the endometrium are reviewed in detail in Chapter 5. Endometrial biomarkers are detailed in Chapter 6. Lymphatic mapping of endometrial cancer is discussed in Chapter 7. Sentinel lymph nodes in endometrial cancer are highlighted in Chapter 8. The current strategies and approaches to treat patients with endometrial cancer are detailed in Chapter 9. Surgical techniques for endometrial cancer are reviewed in Chapter 10. The current treatment of advanced endometrial cancer is discussed in Chapter 11. Adjuvant medical therapeutic modalities are reviewed in Chapter 12. Targeted therapies for advanced endometrial cancer are presented in Chapter 13. The role of ErbB targeted therapy in treating endometrial cancer is discussed in Chapter 14. Finally, the quality of life of women with endometrial cancer is reviewed in Chapter 15. This book is intended for all clinicians and basic medical scientists caring for women with endometrial cancer, including attending surgeons and physicians, clinical fellows, and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology, as well as PhD students and post-doctoral fellows in the basic medical sciences.

Read more less

Book SynopsisAccording to the Global Cancer Observatory, in 2020 the number of new cases of cancer was 19.3 million people in the whole world, with breast, lung, and colorectal cancer comprising 10-11% each of these figures. In the same year, there were almost 10 million deaths from cancer, with lung cancer being the one leading to more deaths (18%). Unfortunately, these figures are only expected to increase, with an estimated incidence of 30.2 million cases in 2040. Thus, cancer is a worldwide public health priority, with a high socio-economic impact. Chemotherapy stands out among the available cancer treatments. Platinum-based chemotherapy is one of the earliest chemotherapeutics introduced to the clinics and it is still the first-line treatment, used alone or in combination with other anti-neoplastic therapy and/or radiation, for many types of cancer in both adults and children. The book Platinum-Based Chemotherapy: Clinical Uses, Efficacy and Side Effects offers the reader a general overview of this therapy, as well as an update on some of the most relevant issues specific to this therapy.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisAny breast operation is a significant event. This book provides information to help to lessen the fear and gives practical advice for patients returning to a normal life.Table of ContentsContents include: an explanation of the benign causes of lumps and pain in the breast; an outline of the different types of cancer of the breast; a description of investigative and diagnostic procedures; a look at preparation for surgery; the different surgical procedures and what to expect after surgery; a discussion on radiotherapy and chemotherapy; an explanation of breast reconstruction.

Read more less

Book SynopsisIntensive research over the last fifteen years has yielded a vast expansion in our understanding of the role of inheritance and genetics in a variety of cancers. Several inherited conditions have been identified which result in a high risk of various cancers; some of these were previously recognised, but the genetic basis underlying them has now been elucidated. This knowledge is now entering the sphere of routine clinical care. Once the preserve of researchers and highly specialised units, genetic testing for cancer predisposition is now accessible to most clinicians via regional genetics units; in the USA patients can access commercial genetic testing facilities. There is a growing evidence base to guide family screening and clinical management of affected individuals. Surgeons, gastroenterologists, gynaecologists, oncologists, endocrinologists and many others need an awareness of these disorders, an understanding of genetic testing and when it is indicated, and how to manage patients with inherited cancer predisposition and their families. Testing for these conditions has potential legal, ethical and financial implications different from those which most clinicians regularly encounter, and continuing scientific and clinical advance means that patients and their doctors will face regular changes in management. This book covers the basic concepts of cancer genetics. The common inherited cancer syndromes are each dealt with in greater depth, with the current management outlined. This book is aimed at all clinicians who may encounter these conditions in their practice. It aims to facilitate identification of high-risk individuals and families, to inform interaction with geneticists and other sub-specialists, to provide a basis for patient management and to stimulate interest in these fascinating conditions.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisThe Research Session held during Eurocancer 1993 reflects a rather surprising paradox: whereas great strides have been made in normal or neoplasic cell research, basic cancer treatment does not seem to have altered in decades and still relies on chemotherapy, radiation-treatment and surgery. Proceedings of the Research workshop held in Eurocancer, Paris, April 1993.

Read more less

Book SynopsisContributions from leading authors in the field of clinical and biological breast cancer research constitute these three chapters: predisposition to breast cancer, carcinogenesis, and early breast cancer screening and management; tumour biology and prognostic; and therapeutics aspects of breast cancer. 21st Meeting of the International Association for Breast Cancer Research, Paris, 1996.

Read more less

Book SynopsisAdrenal Cortical Carcinoma is classically associated with a dismal prognosis. Yet its clinical presentation is changing (more and more classified as ''incidentaloma''). New insights have emerged on its pathophysiological mechanisms (through the genetic elucidation of familial syndromes), and Reference Centers within National and European Networks are now offering more standardised and efficient multidisciplinary clinical management of these difficult patients. All these important aspects are described by experts in nine chapters dealing with epidemiology, prognosis, and clinical management, pathology, molecular pathophysiological mechanisms, modern imaging approaches, surgical and chemotherapeutical approaches of primary and secondary lesions, and the particular aspects of adrenal cortical carcinoma in children. This book, with its many figures and photographs, will be of major interest to endocrinologists, radiologists and nuclear medicine experts, pathologists, surgeons, oncologists, paediatricians. After a thorough reading, one will better recognise a suspicious adrenal ''incidentaloma'', diagnose steroid hypersecretion, suspect a familial disease, consult with the pathologist and surgeon, manipulate difficult drugs like O,p''DDD, participate in multidisciplinary discussions with oncologists, radiotherapeutists, molecular biologists... Modern medicine in action!

Read more less

Book SynopsisNew technological approaches in dermatologic diagnostics, such as surface microscopy and dermoscopy, are continuously advancing. Anatomical structures can be viewed like never before. Through these new techniques the necessity of a new terminology and a new set of dermoscopic criteria has come up. So far, many different and sometimes confusing terms have been used in designating these microscopic features. However, the daily challenge physicians face when evaluating skin lesions acquires immediate access to the current dermoscopic nomenclature and definition. This unique guide provides a comprehensive, current, and accurate A-Z encyclopaedia to clarify the meaning of surface microscopic and dermoscopic terminology including a broad range of both melanocytic and non-melanocytic skin lesions. It will support dermatologists, histopathologists and all other physicians in charge of a biopsy and excision decision.Table of ContentsA.- B.- C.- D.- E.- F.- G.- H.- I.- J.- K.- L.- M.- N.- O.- P.- R.- S.- T.- U.- V.- W.- Z.

Read more less

Book Synopsis

Read more less

Book SynopsisThis volume includes eight chapters that describe recent updates in cancer research. Chapter One highlights the benefits of ancillary/consulting care services within pediatric oncology, including social work, psychology, neuropsychology, expressive therapies, child life, chaplaincy, teachers/school liaisons, rehabilitation therapies, nutrition, and palliative care. Chapter Two discusses various generations of chimeric antigen receptors (CAR) and recent efforts in manufacturing CAR T-cells as a therapy for cancer treatment. Chapter Three explores alternative target pathways for putative therapeutic approaches affecting chronic myeloid leukemia cells. Chapter Four reviews research done on the role of epigenetics in the initiation and progression of thyroid cancer. Chapter Five summarizes the literature that implicates the underlying molecular mechanisms of paclitaxel resistance and the potential therapeutic targets to overcome this resistance. Chapter Six deals with the inhibition of autophagy for instigating temozolomide for increasing induction of apoptosis in glioblastoma. Chapter Seven studies the use of vitamin E for leukemic stem cells reprogramming. Finally, Chapter Eight describes new molecular studies for approaches affecting chronic myeloid leukemia cells.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThe idea of a philosophy of palliative care emerged with Cicely Saunders'' vision for ''a good death'', and was developed further with the WHO definition of palliative care. It is now being applied not only to cancer patients, but to all patients in end of life situations. As this ''palliative care approach'' advances, it is important to pause and comment on its effectiveness. It is a philosophy of patient care, and is therefore open to critique and evaluation.Using the Oxford Textbook of Palliative Medicine, 3rd edition as their basic reference, Randall and Downie present their argument that the palliative care approach has become too busy and over-professionalised, and that it therefore has significant weaknesses. They examine the framework of the specialty - quality of life, autonomy, dignity, patient-centredness, and the priority assigned to relatives in the remit of care - and the moral problems associated with implementing such a philosophy. The resource implications of various hTrade ReviewI think it is timely that we re-examine what it is that we do, which is what this interesting and thought-provoking book does. * Roger Woodruff, Director of Palliative Care, Austin Health, Melbourne, Australia *...the work is honest and realistic. The authors define, acknowledge and justify the limits of what is possible and desirable in the relationship between doctors, other care workers, patients and families in palliative care. I believe it is a product of their intellectual rigour combined with deep and long immersion in the practical realities of the field...[and is] the most important achievement of their work; it is enlightening, shows proper humility and lays waste to the lofty arrogance of the various definitions,'philosophies' and 'position statements' that are generated by some large and powerful institutions. This book has my wholehearted recommendation. * S.C. Allen, The Royal Bournemouth Hospital *Within a slim and readable 226 pages, they expose a significant number of basic inconsistencies and contradictions that they find in the currently accepted 'norms' or the speciality. But rather than leave it at that somewhat negative position, they also defend the achievements of the speciality and proceed to record the positive parts of the current situation. Finally, they present their case for a new philosophical statement to underpin the speciality as it adapts to work in the medical system of the 21st century...an excellent and easily accessible text which I suspect will be referred to a great deal in debates and discussions about the future of Palliative Care. * Oncology News, Vol. 1, Issue 2 *It was/is often stated in book reviews that "this book should on every 's bookshelf". Well, I believe that this book should be in every hospice library bookshelf. It is asking important questions to every palliative care physician and clinician of whatever profession. As a result of reading this book they will be better informed and regard palliative care in a better way. Although the book is a critique it does highlight (at least to me) why palliative care is an essential component of any healthcare set up. * BMA Medical Book Competition 2007 *Table of Contents1. Roots, traditions and philosophy ; 2. Quality of life ; 3. Autonomy, dignity, respect and the patient centred approach ; 4. Relatives ; 5. Control of symptoms and prolongation of life ; 6. Resuscitation and advance statements ; 7. Assessment and treatment of psychosocial and spiritual problems ; 8. Resource allocation ; 9. Critique and reconstruction: some suggestions for a better way

Read more less

Book SynopsisMore and more people living with and beyond cancer seek integrative interventions to complement their conventional cancer care. This second edition of the highly successful Integrative Oncology provides the reader with the most updated information available with new chapters on Music and Expressive Arts Therapies, Naturopathic Oncology, and an integrative approach to Lung Cancer. Integrative medicine is defined as healing-oriented medicine that takes account of the whole person (body, mind, and spirit) as well as all aspects of lifestyle; it emphasizes the therapeutic relationship and makes use of appropriate therapies, both conventional and alternative. This series grows out of a need to organize and make accessible to clinicians the basic principles of integrative medicine in practical application to common health conditions. Each volume focuses on a particular specialty and features well-recognized and authoritative editors and chapter authors. The text is presented in an easy-to-read format featuring case histories, clinical pearls, and useful tables, with all key information highlighted. Series editor Andrew Weil, MD, is Professor and Director of the Arizona Center for Integrative Medicine at the University of Arizona. Dr. Weil''s program was the first such academic program in the U.S., and its stated goal is to combine the best ideas and practices of conventional and alternative medicine into cost effective treatments without embracing alternative practices uncritically.Trade ReviewIntegrative oncology is an exciting new discipline that offers best-practice methods to prevent cancer and support those affected by it on all levels: body, mind, and spirit. This comprehensive book provides meticulous, well-written chapters on proven and yet-to-be-proven methods for enhancing cancer care with integrative oncology. * The ASCO Post *Table of Contents1. Why Integrative Oncology? ; 2. An Integrative Approach to Cancer Prevention ; 3. Molecular Targets of Botanicals Used for Chemoprevention ; 4. Research Methodology Challenges in Integrative Oncology ; 5. Diet and Cancer: Epidemiology and Prevention ; 6. Nutritional Interventions in Cancer ; 7. Botanical Medicine in Integrative Oncology: What is Known? ; 8. Cannabinoids and Cancer ; 9. Botanical-Drug Interactions in Oncology - What Is Known? ; 10. The Antioxidant Debate ; 11. Physical Activity and Cancer ; 12. Massage Therapy ; 13. Mind-Body Medicine in Integrative Cancer Care ; 14. Music and Expressive Arts Therapies ; 15. Energy Medicine and Cancer ; 16. The Role of Spirituality ; 17. Naturopathic Oncology ; 18. Traditional and Modern Chinese Medicine ; 19. Ayurveda and Yoga for Cancer Supportive Care ; 20. Anthroposophic Medicine, Integrative Oncology, and Mistletoe Therapy of Cancer ; 21. Integrative Medicine and Breast Cancer ; 22. Prostate Cancer: An Integrative Approach ; 23. Integrative Medicine in Colorectal Cancer: Role of Energy Balance as Treatment ; 24. Lung Cancer: An Integrative Approach ; 25. Integrative Therapies in Cancer Symptom Management ; 26. Alternative Therapies as Primary Treatments for Cancer ; 27. Communication Issues in Integrative Oncology ; 28. Tending the Spirit in Cancer ; 29. A Patient's Perspective

Read more less

Book SynopsisThe importance of spiritual well-being and the role of meaning in moderating depression, hopelessness and desire for death in terminally-ill cancer and AIDS patients has been well-supported by research, and has led many palliative clinicians to look beyond the role of antidepressant treatment in this population. Clinicians are focusing on the development of non-pharmacologic interventions that can address issues such as hopelessness, loss of meaning, and spiritual well-being in patients with advanced cancer at the end of life. This effort led to an exploration and analysis of the work of Viktor Frankl and his concepts of logotherapy, or meaning-based psychotherapy. While Frankl''s logotherapy was not designed for the treatment of patients with life-threatening illnesses, his concepts of meaning and spirituality have inspired applications in psychotherapeutic work with advanced cancer patients, many of whom seek guidance and help in dealing with issues of sustaining meaning, hope, and uTrade ReviewThis is a priceless resource for those working with patients with advanced cancer and other terminal illnesses. It expertly applies scientifically validated existential treatments in an accessible workbook format for busy practicing clinicians... Unlike so much literature on existential psychotherapy with its grand theories, this book shows how to work with dying patients step by step. Readers will be rewarded with a new-found confidence when working with dying patients... 5 stars! * Doody's Notes *Few would argue with the importance of helping patients sustain a sense of meaning, particularly in the last months of life as they confront death... Well, that's what these little treatment manuals are all about. A carefully developed and structured 8-week psychotherapeutic intervention, for individuals or groups, shown to be of benefit in randomized clinical trials... I was impressed by the potential value of these interventions. In the palliative care setting they could be facilitated by experienced nurses, social workers, counsellors, and pastoral care workers as well as physicians. * IAHPC News *Table of ContentsIntroduction: Treatment Overview ; a. General Guidelines ; b. Intervention Purpose and Goals ; c. Intervention Overview ; d. How to Use the Manual ; 1. Session 1. Concepts & Sources of Meaning: Introductions and Meaning ; 2. Session 2. Cancer & Meaning: Identity Before and After Cancer Diagnosis ; 3. Session 3. Historical Sources of Meaning: Life as Legacy that has been given [past] and Life as Legacy that one lives [present] and gives [future] ; 4. Session 4. Attitudinal Sources of Meaning: Encountering Life's Limitations ; 5. Session 5. Creative Sources of Meaning: 'Creativity, Courage & Responsibility ; 6. Session 6. Experiential Sources of Meaning: Connecting with Life ; 7. Session 7. Transitions: Reflection & Hopes for Future ; References ; Handouts ; Exercises ; Homework

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less